Story excerpt provided by WOUB Digital.
Written by Tom Hodson.
Jeff Wiseman has brought his 30 years of experience in “drug discovery research” in pharmaceuticals to Ohio University and SE Ohio.
Wiseman is the Executive in Residence at the Edison Biotechnology Institute at Ohio University. His primary focus is helping to advance “life sciences technologies” from the laboratory to commercial distribution.
He recently talked with WOUB’s Tom Hodson about the growth and value of biotechnology at Ohio University and in this region. Ohio University is one of the nation’s leaders in research licensing revenue, according to The Association of University Technology Managers (AUTM).
Listen to the complete interview with Jeff Wiseman here.
Originally published October 26, 2015.